Resources

This case study examines the use of advocacy to reduce newborn infections in Bangladesh, specifically the market advocacy efforts by PATH and the Bangladesh Pediatric Association to engage public and private stakeholders to understand the importance of 7.1 percent chlorhexidine digluconate use.

This fact sheet describes PATH’s work to increase access to oxygen therapy for the treatment of life-threatening pneumonia and hypoxemia in newborns and children. Facilitating inclusion of expanded uses of oxygen on the World Health Organization’s Essential Medicines List, as well as the inclusion of oxygen technologies and pulse oximetry in global commodity lists and treatment guidelines, are essential for reducing child mortality.

Purpose: To facilitate counseling activities on key COVida intervention areas, including child development, during home visits.Used by community-based organization activists supported by COVida.

By 2014, concerns about pyrethroid resistance in the Ségou Region of Mali had prompted a shift in indoor residual spraying (IRS) products. Ségou was also expanding a program to provide seasonal malaria chemoprevention to children. This presented an opportunity to analyze the impact of both interventions using passive surveillance data.

The adoption of new products for indoor residual spraying (IRS) is challenged by evidence gaps regarding their impact and cost-effectiveness. To provide evidence to address this gap, we present a retrospective, observational analysis of the epidemiological and entomological impact of IRS with different insecticides using routine indicators of malaria transmission.